Immune Checkpoints in Circulating and Tumor-Infiltrating CD4(+) T Cell Subsets in Colorectal Cancer Patients

Blockade of inhibitory immune checkpoints (ICs) is a promising therapeutic approach; however, it has shown limited success in some cancers including colorectal cancer (CRC). The tumor microenvironment (TME) is largely responsible for response to therapy, and its constituents may provide robust bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Toor, Salman M., Murshed, Khaled, Al-Dhaheri, Mahmood, Khawar, Mahwish, Abu Nada, Mohamed, Elkord, Eyad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928042/
https://www.ncbi.nlm.nih.gov/pubmed/31921188
http://dx.doi.org/10.3389/fimmu.2019.02936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928042/
https://www.ncbi.nlm.nih.gov/pubmed/31921188
http://dx.doi.org/10.3389/fimmu.2019.02936

Ejemplares similares